The effect of stem cell therapy and comprehensive physical therapy in motor and non-motor symptoms in patients with multiple sclerosis: A comparative study

Alia A Alghwiri, Fatima Jamali, Mayis Aldughmi, Hanan Khalil, Alham Al-Sharman, Dana Alhattab, Ali Al-Radaideh, Abdalla Awidi, Alia A Alghwiri, Fatima Jamali, Mayis Aldughmi, Hanan Khalil, Alham Al-Sharman, Dana Alhattab, Ali Al-Radaideh, Abdalla Awidi

Abstract

Introduction: People with multiple sclerosis (PwMS) experience a wide range of disabilities which negatively impact their quality of life (QOL). Several interventions have been used in PwMS such as medication, physical therapy exercises and stem cell therapy to improve their QOL. However, there is a limited evidence on the benefits of combining interventions. The purpose of this study is to explore the effect of combining physical therapy exercises (PTE) and Wharton Jelly mesenchymal stem cell (WJ-MSCs) injections on motor and non-motor symptoms versus each intervention alone in PwMS.

Methods: Sixty PwMS will be allocated to either PTE, WJ-MSCs, or a combined group, followed up for 12 months and examined using a comprehensive battery of measures. Participants in the PTE group will receive 2 sessions per week of a supervised exercise program for 6 months followed by a home exercise program for another 6 months. The WJ-MSCs group will receive 3 WJ-MSCs injections in the first 6 months then they will be encouraged to follow an active life style. The third group will receive both interventions.

Discussion: This study will aid in a better understanding of the combined effect of physical therapy and mesenchymal stem cell therapy. The results from this proposed study may reduce disability, improve QOL in PwMS, and consequently, reduce the cost associated with the life-time care of these individuals worldwide.

Trial registration number: NCT03326505.

Conflict of interest statement

The authors have no conflicts of interest to disclose.

Figures

Figure 1
Figure 1
Flow chart demonstrating the study procedures from screening through study completion.

References

    1. Berger JR, Pocoski J, Preblick R, et al. Fatigue heralding multiple sclerosis. Mult Scler 2013;19:1526–32.
    1. Martin CL, Phillips BA, Kilpatrick TJ, et al. Gait and balance impairment in early multiple sclerosis in the absence of clinical disability. Mult Scler 2006;12:620–8.
    1. Glanz BI, Degano IR, Rintell DJ, et al. Work productivity in relapsing multiple sclerosis: associations with disability, depression, fatigue, anxiety, cognition, and health-related quality of life. Value Health 2012;15:1029–35.
    1. Benedict RH, Wahlig E, Bakshi R, et al. Predicting quality of life in multiple sclerosis: accounting for physical disability, fatigue, cognition, mood disorder, personality, and behavior change. J Neurol Sci 2005;231:29–34.
    1. Federation MSI. Atlas of MS 2013: Mapping Multiple Sclerosis Around the World 2013 12/4/2019]; Available from: .
    1. El-Salem K, Al-Shimmery E, Horany K, et al. Multiple sclerosis in Jordan: a clinical and epidemiological study. J Neurol 2006;253:1210–6.
    1. Davies BL, Arpin DJ, Liu M, et al. Two different types of high-frequency physical therapy promote improvements in the balance and mobility of persons with multiple sclerosis. Arch Phys Med Rehabil 2016;97:2095–101.
    1. Finlayson M, Plow M, Cho C. Use of physical therapy services among middle-aged and older adults with multiple sclerosis. Phys Ther 2010;90:1607–18.
    1. Dalgas U, Stenager E, Ingemann-Hansen T. Multiple sclerosis and physical exercise: recommendations for the application of resistance-, endurance- and combined training. Mult Scler 2008;14:35–53.
    1. Finkelstein J, Lapshin O, Castro H, et al. Home-based physical telerehabilitation in patients with multiple sclerosis: a pilot study. J Rehabil Res Dev 2008;45:1361–73.
    1. Dahbour S, Jamali F, Alhattab D, et al. Mesenchymal stem cells and conditioned media in the treatment of multiple sclerosis patients: clinical, ophthalmological and radiological assessments of safety and efficacy. CNS Neurosci Ther 2017;23:866–74.
    1. Bai L, Lennon DP, Caplan AI, et al. Hepatocyte growth factor mediates mesenchymal stem cell-induced recovery in multiple sclerosis models. Nat Neurosci 2012;15:862–70.
    1. Gerdoni E, Gallo B, Casazza S, et al. Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis. Ann Neurol 2007;61:219–27.
    1. Marmotti A, Mattia S, Castoldi F, et al. Allogeneic umbilical cord-derived mesenchymal stem cells as a potential source for cartilage and bone regeneration: an in vitro study. Stem Cells Int 2017;1732094:1–6.
    1. Alhattab D, Jamali F, Ali D, et al. An insight into the whole transcriptome profile of four tissue-specific human mesenchymal stem cells. Regen Med 2019;14:841–65.
    1. Jin HJ, Bae YK, Kim M, et al. Comparative analysis of human mesenchymal stem cells from bone marrow, adipose tissue, and umbilical cord blood as sources of cell therapy. Int J Mol Sci 2013;14:17986–8001.
    1. Khan F, Amatya B. Rehabilitation in multiple sclerosis: a systematic review of systematic reviews. Arch Phys Med Rehabil 2017;98:353–67.
    1. Pangman VC, Sloan J, Guse L. An examination of psychometric properties of the mini-mental state examination and the standardized mini-mental state examination: implications for clinical practice. Appl Nurs Res 2000;13:209–13.
    1. Seshareddy K, Troyer D, Weiss ML. Method to isolate mesenchymal-like cells from Wharton's Jelly of umbilical cord. Methods Cell Biol 2008;86:101–19.
    1. Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006;8:315–7.
    1. Forsberg A, von Koch L, Nilsagard Y. Effects on balance and walking with the CoDuSe balance exercise program in people with multiple sclerosis: a multicenter randomized controlled trial. Mult Scler Int 2016;7076265:1–6.
    1. Latimer-Cheung AE, Pilutti LA, Hicks AL, et al. Effects of exercise training on fitness, mobility, fatigue, and health-related quality of life among adults with multiple sclerosis: a systematic review to inform guideline development. Arch Phys Med Rehabil 2013;94:1800–28.
    1. Camarda SRdA, Tebexreni AS, Páfaro CN, et al. Comparison of maximal heart rate using the prediction equations proposed by Karvonen and Tanaka. Arq Bras Cardiol 2008;91:311–4.
    1. Siengsukon CF, Aldughmi M, Kahya M, et al. Randomized controlled trial of exercise interventions to improve sleep quality and daytime sleepiness in individuals with multiple sclerosis: a pilot study. Mult Scler J Exp Transl Clin 2016;2:1–9.
    1. Khalil H, Quinn L, van Deursen R, et al. Adherence to use of a home-based exercise DVD in people with Huntington disease: participants’ perspectives. Phys Ther 2012;92:69–82.
    1. Khalil H, Busse M, Quinn L, et al. A pilot study of a minimally supervised home exercise and walking program for people with Parkinson's disease in Jordan. Neurodegener Dis Manag 2017;7:73–84.
    1. Billinger SA, Mattlage AE, Ashenden AL, et al. Aerobic exercise in subacute stroke improves cardiovascular health and physical performance. J Neurol Phys Ther 2012;36:159–65.
    1. Goldman MD, Marrie RA, Cohen JA. Evaluation of the six-minute walk in multiple sclerosis subjects and healthy controls. Mult Scler 2008;14:383–90.
    1. Shumway-Cook A, Baldwin M, Polissar NL, et al. Predicting the probability for falls in community-dwelling older adults. Phys Ther 1997;77:812–9.
    1. Alghwiri AA. Reliability and validity of the Arabic dynamic gait index in people poststroke. Top Stroke Rehabil 2014;21:173–9.
    1. Alghwiri AA, Alghadir AH, Al-Momani MO, et al. The activities-specific balance confidence scale and berg balance scale: reliability and validity in Arabic-speaking vestibular patients. J Vestib Res 2016;25:253–9.
    1. Berg KO, Wood-Dauphinee SL, Williams JI, et al. Measuring balance in the elderly: validation of an instrument. Can J Public Health 1992;83: Suppl 2: S7–11.
    1. Ng SS, Hui-Chan CW. The timed up & go test: its reliability and association with lower-limb impairments and locomotor capacities in people with chronic stroke. Arch Phys Med Rehabil 2005;86:1641–7.
    1. Cattaneo D, Jonsdottir J, Repetti S. Reliability of four scales on balance disorders in persons with multiple sclerosis. Disabil Rehabil 2007;29:1920–5.
    1. Cattaneo D, Regola A, Meotti M. Validity of six balance disorders scales in persons with multiple sclerosis. Disabil Rehabil 2006;28:789–95.
    1. Wade DT, Collin C. The Barthel ADL index: a standard measure of physical disability? Int Disabil Stud 1988;10:64–7.
    1. Collin C, Wade DT, Davies S, et al. The Barthel ADL index: a reliability study. Int Disabil Stud 1988;10:61–3.
    1. Rollnik JD. The early rehabilitation Barthel index (ERBI). Rehabilitation (Stuttg) 2011;50:408–11.
    1. Severijns D, Lamers I, Kerkhofs L, et al. Hand grip fatigability in persons with multiple sclerosis according to hand dominance and disease progression. J Rehabil Med 2015;47:154–60.
    1. Mathiowetz V, Volland G, Kashman N, et al. Adult norms for the box and block test of manual dexterity. Am J Occup Ther 1985;39:386–91.
    1. Halaweh H, Svantesson U, Rosberg S, et al. Cross-cultural adaptation, validity and reliability of the Arabic Version of the falls efficacy scale-international (FES-I). Med Princ Pract 2016;25:1–7.
    1. Abdel-Khalek AM. Internal consistency of an Arabic adaptation of the Beck depression inventory in four Arab countries. Psychol Rep 1998;82:264–6.
    1. Beck AT, Ward CH, Mendelson M, et al. An inventory for measuring depression. Arch Gen Psychiatry 1961;4:561–71.
    1. Tellez N, Rio J, Tintore M, et al. Does the modified fatigue impact scale offer a more comprehensive assessment of fatigue in MS? Mult Scler 2005;11:198–202.
    1. Khalil H, Al-Shorman A, Alghwiri AA, et al. Cross cultural adaptation and psychometric evaluation of an Arabic version of the modified fatigue impact scale in people with multiple sclerosis. Mult Scler Relat Disord 2020;39:101878.
    1. Suleiman KH, Yates BC, Berger AM, et al. Translating the Pittsburgh sleep quality index into Arabic. West J Nurs Res 2010;32:250–68.
    1. Buysse DJ, Reynolds CF, 3rd, Monk TH, et al. The Pittsburgh sleep quality index: a new instrument for psychiatric practice and research. Psychiatry Res 1989;28:193–213.
    1. Ahmed AE, Fatani A, Al-Harbi A, et al. Validation of the Arabic version of the Epworth sleepiness scale. J Epidemiol Glob Health 2014;4:297–302.
    1. Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991;14:540–5.
    1. Stroop JR. Studies of interference in serial verbal reactions. J Exp Psychol Gen 1992;121:15–23.
    1. Al-Ghatani A, Obonsawin M, Al-Moutaery K. The Arabic version of the Stroop test and its equivalency to the English version. Pan Arab J Neurosurg 2010;14:112–5.
    1. Parmenter BA, Weinstock-Guttman B, Garg N, et al. Screening for cognitive impairment in multiple sclerosis using the symbol digit modalities test. Mult Scler 2007;13:52–7.
    1. Jensen TS, Gottrup H, Sindrup SH, et al. The clinical picture of neuropathic pain. Eur J Pharmacol 2001;429:1–1.
    1. Ware JE, Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473–83.
    1. Coons SJ, Alabdulmohsin SA, Draugalis JR, et al. Reliability of an Arabic version of the RAND-36 health survey and its equivalence to the US-English version. Med care 1998;36:428–32.
    1. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444–52.
    1. Udupa JK, Wei L, Samarasekera S, et al. Multiple sclerosis lesion quantification using fuzzy-connectedness principles. IEEE Trans Med Imaging 1997;16:598–609.

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi